Targos Molecular Pathology GmbH
General information
Targos Molecular Pathology GmbH
Germaniastrasse 7
34119 Kassel, Hessen
Germany
Contact person: Thomas Henkel, Chief Executive Officer
Company main phone: +49 (561) 500450
Company main fax: +49 (561) 50045355
Website: https://www.targos-gmbh.de
Germaniastrasse 7
34119 Kassel, Hessen
Germany
Contact person: Thomas Henkel, Chief Executive Officer
Company main phone: +49 (561) 500450
Company main fax: +49 (561) 50045355
Website: https://www.targos-gmbh.de
| Year founded: | 2005 |
| Source of foundation: | Independent foundation |
| Name of foundation source: | Founded by Dr. Thomas Henkel, Prof. Josef Rüschoff and Dr. Reinhard Büttner. |
Corporate description / mission:
Targos’s core service business is to provide standardized development and application of clinical biomarkers for the international pharmaceutical and diagnostic industry. The company also supports the introduction of new Companion Diagnostic assays into the clinical routine by performing Targos Advance training courses for the international standardization of biomarkers. The company is a fully GCP-compliant central laboratory that is inspected by the U.S. Food and Drug Administration (FDA). Targos Molecular Pathology GmbH is accredited by the College of American Pathologists (CAP) and the Clinical Laboratory Improvement Amendments (CLIA).
Targos’s core service business is to provide standardized development and application of clinical biomarkers for the international pharmaceutical and diagnostic industry. The company also supports the introduction of new Companion Diagnostic assays into the clinical routine by performing Targos Advance training courses for the international standardization of biomarkers. The company is a fully GCP-compliant central laboratory that is inspected by the U.S. Food and Drug Administration (FDA). Targos Molecular Pathology GmbH is accredited by the College of American Pathologists (CAP) and the Clinical Laboratory Improvement Amendments (CLIA).
State of ownership: Private / independent
Headquarters: Yes
Headquarters: Yes
Categorization
| Sector: |
|
| Subsector: |
|
| Business model: |
|
| Customer segments: |
|
Summary Products / Services / Technologies
Description of products:
Services:
Digital Pathology
DNA-RNA_Isolation
Expression Profiling
In Situ Hybridization (ISH), etc.
Services:
Digital Pathology
DNA-RNA_Isolation
Expression Profiling
In Situ Hybridization (ISH), etc.
Collaborations & Clients
Partnering strategy / collaborations:
AKESOgen, USA
WuXi PharmaTech, China
Pathologie Nordhessen, Germany
Institute of Pathology, University Hospital Cologne, Germany
Department of Pathology, University Medical Center Göttingen (UMG), Germany.
AKESOgen, USA
WuXi PharmaTech, China
Pathologie Nordhessen, Germany
Institute of Pathology, University Hospital Cologne, Germany
Department of Pathology, University Medical Center Göttingen (UMG), Germany.
© 2023 Biotechgate by Venture Valuation